Across the recent three months, 25 analysts have shared their insights on Chewy CHWY, expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 10 | 9 | 1 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 6 | 4 | 0 | 0 |
| 2M Ago | 0 | 0 | 2 | 0 | 0 |
| 3M Ago | 4 | 4 | 2 | 1 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $23.34, along with a high estimate of $32.00 and a low estimate of $16.00. This current average has increased by 0.65% from the previous average price target of $23.19.
Deciphering Analyst Ratings: An In-Depth Analysis
A clear picture of Chewy's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Bellinger | Mizuho | Raises | Neutral | $20.00 | $18.00 |
| Mark Mahaney | Evercore ISI Group | Raises | In-Line | $22.00 | $19.00 |
| Lee Horowitz | Deutsche Bank | Raises | Hold | $20.00 | $18.00 |
| Doug Anmuth | JP Morgan | Raises | Overweight | $28.00 | $22.00 |
| Rick Patel | Raymond James | Raises | Outperform | $24.00 | $19.00 |
| Michael Lasser | UBS | Raises | Neutral | $21.00 | $19.00 |
| Seth Basham | Wedbush | Raises | Outperform | $28.00 | $25.00 |
| Peter Keith | Piper Sandler | Raises | Neutral | $22.00 | $16.00 |
| Lauren Schenk | Morgan Stanley | Raises | Overweight | $28.00 | $27.00 |
| Anna Andreeva | Needham | Raises | Buy | $30.00 | $25.00 |
| Seth Basham | Wedbush | Maintains | Outperform | $25.00 | $25.00 |
| Rick Patel | Raymond James | Lowers | Outperform | $19.00 | $20.00 |
| Steven Zaccone | Citigroup | Lowers | Neutral | $16.00 | $18.00 |
| Peter Keith | Piper Sandler | Lowers | Neutral | $16.00 | $19.00 |
| Alexandra Steiger | Goldman Sachs | Lowers | Buy | $32.00 | $36.00 |
| Steven Shemesh | RBC Capital | Lowers | Outperform | $22.00 | $35.00 |
| Kaumil Gajrawala | Jefferies | Lowers | Buy | $25.00 | $27.00 |
| Peter Keith | Piper Sandler | Lowers | Neutral | $19.00 | $21.00 |
| Curtis Nagle | B of A Securities | Lowers | Underperform | $16.50 | $17.00 |
| Doug Anmuth | JP Morgan | Lowers | Overweight | $22.00 | $25.00 |
| Eric Sheridan | Goldman Sachs | Lowers | Buy | $32.00 | $36.00 |
| Seth Basham | Wedbush | Maintains | Outperform | $25.00 | - |
| Anna Andreeva | Needham | Maintains | Buy | $25.00 | - |
| David Bellinger | Mizuho | Announces | Neutral | $18.00 | - |
| Nicholas Jones | JMP Securities | Maintains | Market Outperform | $28.00 | - |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Chewy. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Chewy compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Chewy's stock. This examination reveals shifts in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Chewy's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Chewy analyst ratings.
Discovering Chewy: A Closer Look
Chewy is the largest e-commerce pet care retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Unraveling the Financial Story of Chewy
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Chewy displayed positive results in 3 months. As of 30 April, 2024, the company achieved a solid revenue growth rate of approximately 3.12%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Chewy's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 2.32%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Chewy's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 11.6%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.09%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.81, Chewy adopts a prudent financial strategy, indicating a balanced approach to debt management.
The Significance of Analyst Ratings Explained
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
